← Open Payments lookup

DEBORAH FERGUSON: Open Payments

NPI 1952079709 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,155 in 51 payments from 9 companies in 2025. Trend: 2023 $243 · 2024 $1,272 · 2025 $1,155

Food & beverage: $1,155
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.10$250
E.R. Squibb & Sons, L.L.C.8$219
Otsuka America Pharmaceutical, Inc.9$194
ABBVIE INC.7$148
Teva Pharmaceuticals USA, Inc.5$108
Almatica Pharma LLC5$95
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$79
Axsome Therapeutics, Inc.2$47
Supernus Pharmaceuticals, Inc.1$14

Products named: INGREZZA, COBENFY, REXULTI, VRAYLAR, LOREEV XR, AUSTEDO XR, CAPLYTA, Auvelity.

Industry payments across TX — which companies pay providers there.